Found: 64
Select item for more details and to access through your institution.
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1641, doi. 10.1007/s10637-021-01152-z
- By:
- Publication type:
- Article
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 693, doi. 10.1007/s10637-018-0688-4
- By:
- Publication type:
- Article
The Role of Integrins in Colorectal Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 21
- By:
- Publication type:
- Article
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 5, p. 1, doi. 10.1002/cti2.1392
- By:
- Publication type:
- Article
Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.
- Published in:
- Science & Engineering Ethics, 2018, v. 24, n. 1, p. 307, doi. 10.1007/s11948-017-9880-8
- By:
- Publication type:
- Article
Hyperprogression under Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 11, p. 2674, doi. 10.3390/ijms20112674
- By:
- Publication type:
- Article
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00648-0
- By:
- Publication type:
- Article
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00648-0
- By:
- Publication type:
- Article
Response: Re: Dose Escalation Methods in Phase I Cancer Clinical Trials.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Dose Escalation Methods in Phase I Cancer Clinical Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 10, p. 708, doi. 10.1093/jnci/djp079
- By:
- Publication type:
- Article
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156382
- By:
- Publication type:
- Article
Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, n. 3, p. 195, doi. 10.1111/j.1755-3768.2012.02402.x
- By:
- Publication type:
- Article
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
- Published in:
- Current Oncology, 2023, v. 30, n. 10, p. 9090, doi. 10.3390/curroncol30100657
- By:
- Publication type:
- Article
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Is Primary Poorly Differentiated Sarcomatoid Malignancy of the Parotid Gland Sarcomatoid Undifferentiated/Dedifferentiated Melanoma? Report of Three Unusual Cases Diagnosed by Fine-Needle Aspiration Combined with Histological, Immunohistochemical, and Molecular Analyses
- Published in:
- Acta Cytologica, 2024, v. 68, n. 2, p. 107, doi. 10.1159/000538070
- By:
- Publication type:
- Article
First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE.
- Published in:
- Cancer Reports, 2023, v. 6, n. 5, p. 1, doi. 10.1002/cnr2.1804
- By:
- Publication type:
- Article
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1467
- By:
- Publication type:
- Article
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Optimizing drug development in oncology by clinical trial simulation: Why and how?
- Published in:
- Briefings in Bioinformatics, 2018, v. 19, n. 6, p. 1203, doi. 10.1093/bib/bbx055
- By:
- Publication type:
- Article
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.813
- By:
- Publication type:
- Article
Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy.
- Published in:
- BioDrugs, 2020, v. 34, n. 4, p. 463, doi. 10.1007/s40259-020-00425-y
- By:
- Publication type:
- Article
Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 5, p. 594, doi. 10.1002/1878-0261.12180
- By:
- Publication type:
- Article
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 783, doi. 10.1016/j.molonc.2014.12.003
- By:
- Publication type:
- Article
Absolute lymphocyte count after COVID-19 vaccination is associated with vaccine-induced hypermetabolic lymph nodes on <sup>18</sup>F-FDG PET/CT: a focus in breast cancer care.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.263082
- By:
- Publication type:
- Article
Precision cancer medicine: Concepts, current practice, and future developments.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 455, doi. 10.1111/joim.13709
- By:
- Publication type:
- Article
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 10, p. 901, doi. 10.1007/s00066-023-02080-y
- By:
- Publication type:
- Article
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.
- Published in:
- Oncologist, 2015, v. 20, n. 6, p. 653, doi. 10.1634/theoncologist.2015-0008
- By:
- Publication type:
- Article
Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051039
- By:
- Publication type:
- Article
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
NUT carcinoma in children and adults: A multicenter retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29516-w
- By:
- Publication type:
- Article
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 6, p. 431, doi. 10.1177/1758834017708742
- By:
- Publication type:
- Article
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 20, p. 4981, doi. 10.1002/cncr.27520
- By:
- Publication type:
- Article
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86816-9
- By:
- Publication type:
- Article
Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00074
- By:
- Publication type:
- Article
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 4, p. 399, doi. 10.1007/s40268-021-00362-3
- By:
- Publication type:
- Article
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
- Published in:
- Head & Neck, 2024, v. 46, n. 6, p. 1253, doi. 10.1002/hed.27739
- By:
- Publication type:
- Article
Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature.
- Published in:
- Head & Neck, 2023, v. 45, n. 7, p. 1619, doi. 10.1002/hed.27371
- By:
- Publication type:
- Article
Curative high‐dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
- Published in:
- Head & Neck, 2022, v. 44, n. 11, p. 2452, doi. 10.1002/hed.27153
- By:
- Publication type:
- Article
Prognostic indicators for survival in head and neck squamous cell carcinomas: Analysis of a series of 621 cases.
- Published in:
- Head & Neck, 2005, v. 27, n. 9, p. 801, doi. 10.1002/hed.20254
- By:
- Publication type:
- Article
FDG PET/CT for assessing tumour response to immunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 1, p. 238, doi. 10.1007/s00259-018-4171-4
- By:
- Publication type:
- Article
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29–December 1, 2018, Athens, Greece.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1391, doi. 10.1007/s00262-019-02364-2
- By:
- Publication type:
- Article
Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.
- Published in:
- Bioinformatics, 2014, v. 30, n. 24, p. 3443, doi. 10.1093/bioinformatics/btu436
- By:
- Publication type:
- Article
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz055
- By:
- Publication type:
- Article
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 1, p. 208, doi. 10.20892/j.issn.2095-3941.2019.0153
- By:
- Publication type:
- Article
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3441, doi. 10.3390/cancers15133441
- By:
- Publication type:
- Article
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2681, doi. 10.3390/cancers15102681
- By:
- Publication type:
- Article